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Review
Astrocyte-Neuron Reciprocal 
Signaling
Being unable to generate action potentials, astrocytes 
were for a long time considered nonexcitable cells. 
However, in studies from the 1990s, a Ca2+-based form of 
excitability underlying long-distance communication 
between astrocytes in cultures was revealed by the obser-
vation that Ca2+ increases evoked in individual astrocytes 
by the neurotransmitter glutamate could propagate to 
neighboring astrocytes as an intercellular Ca2+ wave 
(Charles and others 1991; Cornell-Bell and others 1990; 
Finkbeiner 1992). This pioneering finding challenged the 
common belief that astrocytes merely act in the brain as 
neuron-supportive elements and paved the way for a new 
era in astrocyte research. Studies in brain slice prepara-
tions then reported that astrocytes respond to the synaptic 
release of glutamate (Pasti and others 1997; Porter and 
McCarthy 1996), GABA (Kang and others 1998), nor-
adrenaline (Duffy and MacVicar 1995; Kulik and others 
1999), and acetylcholine (Araque and others 2002; 
Navarrete and others 2012; Shelton and McCarthy 2000; 
Takata and others 2011) with complex, often repetitive 
cytosolic Ca2+ elevations, which primarily depend on the 
activation of G protein–coupled metabotropic receptors 
(Verkhratsky and Kettenmann 1996; Verkhratsky and 
others 1998) linked to phospholipase C, production of 
inositol 1,4,5-trisphosphate (InsP3), activation of InsP3 
receptors, and finally, release of Ca2+ from intracellular 
Ca2+ compartments (Berridge 1993; Haydon and 
Carmignoto 2006; Pozzan and others 1994; Shigetomi 
and others 2011). Brain slice results were then validated 
in in vivo experiments that used imaging of fluorescence 
Ca2+ signals by two-photon laser scanning microscopy in 
anesthetized as well as awake, freely moving mice. By 
using this new in vivo approach, Hirase and colleagues 
(2004) could reveal neuronal activity–evoked Ca2+ eleva-
tions in the large majority of cortical astrocytes. 
Correlated Ca2+ increases between adjacent astrocytes 
were also detected, suggesting that in the neuron-astro-
cyte network, in vivo neurons can signal simultaneously 
to multiple astrocytes. Subsequent studies confirmed that 
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Abstract
During the last 20 years, it has been well established that a finely tuned, continuous crosstalk between neurons and 
astrocytes not only critically modulates physiological brain functions but also underlies many neurological diseases. 
In particular, this novel way of interpreting brain activity is markedly influencing our current knowledge of epilepsy, 
prompting a re-evaluation of old findings and guiding novel experimentation. Here, we review recent studies that have 
unraveled novel and unique contributions of astrocytes to the generation and spread of convulsive and nonconvulsive 
seizures and epileptiform activity. The emerging scenario advocates an overall framework in which a dynamic and 
reciprocal interplay among astrocytic and neuronal ensembles is fundamental for a fuller understanding of epilepsy. In 
turn, this offers novel astrocytic targets for the development of those really novel chemical entities for the control of 
convulsive and nonconvulsive seizures that have been acknowledged as a key priority in the management of epilepsy.
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astrocytes from different brain regions, including the 
olfactory bulb (Petzold and others 2008), cerebellum, and 
neocortex (Schummers and others 2008; Wang and oth-
ers 2006), can respond to sensory stimulation with com-
plex Ca2+ elevations. The amplitude, frequency, kinetics, 
and also spatial extent of astrocyte Ca2+ elevations were 
revealed to be strictly dependent on the pattern and 
strength of neuronal activity (Pasti and others 1997; Todd 
and others 2010), suggesting an astrocyte encoding of 
neuronal information (Bezzi and others 1998; Kang and 
others 1998; Pasti and others 1997).
These studies proved beyond a doubt that neurons 
“excite” astrocytes through the same signals that transfer 
information to postsynaptic neurons. What is most rele-
vant for the topic of this article is that this “neuronal exci-
tation” promotes in astrocytes either a feedback or a 
feedforward signal or both that can take the form of a 
Ca2+-dependent release of diverse neuroactive molecules, 
the so-called gliotransmitters, which contribute to the con-
trol of neuronal network excitability (Fig. 1). Among 
these are classic chemical transmitters, such as glutamate 
(Bezzi and others 1998; Parpura and others 1994), 
D-serine (Henneberger and others 2010; Zhuang and oth-
ers 2010), ATP (Zhang and others 2003), (Bowser and 
Khakh 2004) and GABA (Kozlov and others 2006; Le 
Meur and others 2012), but also vasoactive agents, such 
as prostaglandins, and inflammatory signals, such as 
interleukin-1β (IL-β), high-mobility group box 1 
(HMGB1), and tumor necrosis factor α (Bezzi and others 
2001; Maroso and others 2010; Vezzani and others 2008). 
The regulated, activity-dependent release of different 
gliotransmitters has been shown 1) to modulate short- and 
long-term changes in synaptic transmission (Brockhaus 
and Deitmer 2002; Henneberger and others 2010; Jourdain 
and others 2007; Panatier and others 2006; Pascual and 
others 2005; Pasti and others 1997; Perea and Araque 
2007; Serrano and others 2006; Shigetomi and others 
2011; Zhang and others 2003), 2) to control cerebral blood 
flow (Haydon and Carmignoto 2006; Petzold and others 
2008; Zonta and others 2003), 3) to favor neuronal syn-
chrony in the neuronal network (Angulo and others 2004; 
Fellin and others 2004), and 4) to contribute to brain 
inflammatory and immune responses (Aronica and others 
2012; Hamby and Sofroniew 2010) (Fig. 1). While our 
effort in the evaluation of the richness in gliotransmitter 
modulatory actions in the brain leads to a new understand-
ing of the astrocyte’s role in brain function, we are also 
beginning to realize how deep and wide the impact of 
Figure 1. Regulated release of gliotransmitters that can affect epileptiform activities. (1) Classic neurotransmitters activate 
G protein–coupled receptors (GPCRs) and cytosolic Ca2+ elevations in astrocytes. (2) Transient receptor potentials, such as 
TRPA1, mediate Ca2+ influx and contribute to cytosolic Ca2+ regulation. The gliotransmitters that contribute to the regulation of 
neural network excitability, such as glutamate, D-serine, GABA, and ATP, are released via both Ca2+-dependent (3) and Ca2+-
independent (4), nonmutually exclusive mechanisms. (5) Other signaling molecules, including inflammatory mediators, such as 
prostaglandins (PGs) and diverse cytokines, are also released, but through undefined mechanisms. By targeting microglia, neurons, 
and also astrocytes, these molecules can enhance seizure generation.
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gliotransmission might be on the pathogenesis of different 
brain disorders, including epilepsy (Fig. 2).
Astrocytes and Epilepsy
Epilepsy is a neurological disease that is characterized by 
the periodic occurrence of spontaneous seizures, which 
can be convulsive or nonconvulsive in nature depending 
on the type of epilepsy (Noebels and others 2012). Among 
the most common and severe forms of convulsive epilep-
sies is temporal lobe epilepsy (TLE). The clinical mani-
festation of this disorder is represented by recurrent 
seizures that arise as an intense, synchronous discharge in 
a relatively high number of neurons from a restricted 
region of the medial (mTLE) or lateral temporal lobe, that 
is, the epileptogenic focus, and eventually generalize to 
both temporal lobes and extratemporal structures through 
a progressive recruitment of other neuronal populations 
(Avoli and others 2002; Cammarota and others 2013; 
Pinto and others 2005; Traub and Wong 1982; Trevelyan 
and others 2006). As we mentioned above, through the 
release of different gliotransmitters, astrocytes contribute 
to the regulation of both neuronal excitability and synap-
tic transmission and favor neuronal synchrony (Fellin and 
others 2004). The reactive gliosis revealed from neuro-
surgical specimens of patients presenting with mTLE 
may have an impact on this astrocyte signaling, leading to 
an increase in local network excitability and synchronous 
discharges that predispose neurons to generate focal epi-
leptiform activities in TLE. In support of this view, vari-
ous membrane channels, receptors, and transporters in 
astrocytic membranes are altered in the epileptic brain. 
Excitingly, recent evidence, reviewed below, suggests 
that in the course of the pathogenesis of mTLE, these 
glial changes alter homeostatic network functions, tem-
porally precede alterations in neurons, and thus seem to 
be causative for the disorder.
At the other end of the clinical spectrum of epilepsies are 
the nonconvulsive absence seizures, which consist of sud-
den and brief periods of impairment of consciousness that 
are always accompanied by generalized and synchronous 
spike and wave discharges on electroencephalograms 
(Avoli 2012; Blumenfeld 2005; Crunelli and Leresche 
2002; Panayiotopoulos 1997). Absence seizures are present, 
either alone or most commonly in association with convul-
sive seizures, in many idiopathic generalized epilepsies and 
are known to be generated by paroxysmal activity within 
cortical and thalamic networks with little or no involvement 
of other brain regions (Bai and others 2010; Crunelli and 
Leresche 2002; Vergnes and Marescaux 1992; Williams 
1953). Differently from convulsive seizures, clinical evi-
dence indicates that drugs that increase GABAergic func-
tion aggravate and induce absence seizures in patients with 
absence seizures and in healthy individuals, respectively 
(Ettinger and others 1999; Panayiotopoulos 2001; Perucca 
and others 1998). Thus, an increased GABAergic function 
may be an underlying cause of these seizures: indeed, it has 
been demonstrated that the enhancement of tonic GABA
A
 
receptor function in the thalamus of genetic absence epi-
lepsy models is due to a malfunction of the astrocytic GABA 
transporter GAT-1 (Cope and others 2009).
Figure 2. A schematic drawing of the abnormal electrical 
activity during epileptic seizures. Absence and temporal 
lobe seizures (see electroencephalogram traces) originate 
from malfunctions in neurons (classic view, top circle) or in 
the finely tuned crosstalk between astrocytic (green) and 
neuronal (red) networks (novel view, bottom circle).
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In this review, we summarize the current evidence of 
astrocyte dysfunctions in epilepsy and discuss potential 
underlying mechanisms (see also Sifert and others 2006, 
2010). Specifically, we discuss how reciprocal signaling 
between neurons and astrocytes at the level of local brain 
circuits may contribute to the generation of epileptogenic 
foci in mTLE models. We also clearly demonstrate a crit-
ical role of astrocytes in the disturbance of K+ and trans-
mitter homeostasis, as well as GABA transporter function 
and cytokine regulation, and the impact that these abnor-
malities have on the generation of both convulsive and 
nonconvulsive seizures. Thus, although research on 
astrocytes in epilepsy is still in its infancy, these findings 
might eventually lead to a classification of mTLE and 
absence seizures as disorders of astrocyte-neuron signal-
ing rather than neuronal diseases. Importantly, because 
currently available anticonvulsant drugs and therapies are 
insufficient to control mTLE and absence seizures in 
about one third of patients, ongoing research on astro-
cytic abnormalities in epilepsy is providing promising 
new astrocytic targets, which may lead to more specific 
antiepileptogenic therapeutic strategies.
K Channels, Gap Junctions, and 
Aquaporins in mTLE
K+ Uptake and K+ Spatial Buffering
Neuronal activity elicits transient increases in the extra-
cellular potassium concentration ([K+]
o
), which under 
pathological conditions like epilepsy can reach up to 12 
mM (Heinemann and Lux 1977). Even moderate rises in 
[K+]
o
 increase neuronal excitability and synaptic trans-
mission (Walz 2000), underscoring the necessity of tight 
control of K+ homeostasis for normal brain function. This 
task is mainly accomplished by astrocytes, which display 
very negative resting potentials due to a high resting per-
meability for K+. Responsible for this property are 
inwardly rectifying K+ channels of the Kir4.1 subtype 
(Seifert and others 2009) (Fig. 3). Astrocytes control 
[K+]
o
 by two mechanisms: K+ uptake and spatial buffer-
ing. Net uptake of K+ is mainly mediated by Na+/K+ 
pumps and Na+/K+/Cl– co-transporters (Kofuji and 
Newman 2004). It is rather unlikely that this mechanism 
alone is sufficient for efficient clearance of excess [K+]
o
 
because intracellular K+ accumulation results in water 
influx and cell swelling. The spatial buffering model 
(Orkand and others 1966) describes another more effec-
tive mechanism for [K+]
o
 clearance. It is based on the fact 
that astrocytes are electrically connected to each other via 
gap junction (GJ) channels to form a functional syncy-
tium (Fig. 3). According to the spatial buffering model, 
excessive extracellular K+ is taken up by astrocytes at 
sites of high neuronal activity, redistributed through the 
astrocytic network, and released at regions of lower [K+]
o
. 
This uptake and release of K+ occur passively, driven by 
the respective electrochemical gradients. Kir4.1 channels 
are particularly well suited for this task because they pos-
sess a high open probability at rest and their conductance 
increases at high [K+]
o
.
Kir4.1 Channels and K+ Buffering in Epilepsy
Increased [K+]
o
 has been associated with the pathophysi-
ology of epilepsy (Fisher and others 1976), and it is 
known that high [K+]
o
 is sufficient to trigger epileptiform 
activity in vitro (Traynelis and Dingledine 1988). To 
assess the impact of Kir4.1 channels in K+ buffering, the 
effect of Ba2+-induced Kir channel block on stimulus-
triggered rises in [K+]
o
 or iontophoretically applied K+ 
was analyzed. In these experiments, Ba2+ enhanced [K+]
o
 
accumulation under control conditions, but not in scle-
rotic hippocampi, indicating the disturbance of Ba2+-
sensitive K+ uptake in sclerosis (Kivi and others 2000). 
This hypothesis was confirmed with patch clamp analy-
sis, demonstrating reduced Kir currents in the sclerotic 
CA1 region of specimens from patients with mTLE 
(Bordey and Sontheimer 1998; Hinterkeuser and others 
2000). Western blot (Das and others 2012) and immuno-
histochemistry (Heuser and others 2012) also revealed a 
significant loss of the Kir4.1 protein in human hippocam-
pal sclerosis (HS). These studies imply that impaired K+ 
clearance and increased seizure susceptibility in mTLE-
HS result from the reduced expression of Kir4.1 chan-
nels. However, it remains unclear whether this reduction 
represents a cause, effect, or adaptive response in TLE. In 
favor of a causative role, David and colleagues (2009) 
showed in an albumin model of epilepsy that Kir4.1 
down-regulation occurs before the onset of epileptic 
activity. However, another study performed in a kainate 
model found no changes in astrocytic Kir currents in 
post–status epilepticus (SE) (Takahashi and others 2010).
Further support for a crucial role of Kir4.1 in glial K+ 
buffering emerged from Kir4.1 knockout mice. Global 
deletion of Kir4.1 resulted in motor impairments and pre-
mature death (Neusch and others 2001). Mice with glia-
specific deletion of Kir4.1 (cKir4.1–/– mice) displayed a 
similarly severe phenotype and demonstrated that loss of 
Kir4.1 causes epilepsy (Chever and others 2010; Haj-
Yasein and others 2011).
Missense variations in KCNJ10, the gene encoding 
Kir4.1, have been linked to seizure susceptibility in man 
(Buono and others 2004). Loss-of-function mutations in 
KCNJ10 underlie an autosomal recessive disorder char-
acterized by seizures, ataxia, sensorineural deafness, 
mental retardation, and tubulopathy (EAST/SeSAME 
syndrome) (Bockenhauer and others 2009; Scholl and 
others 2009). Patients suffering from this disorder display 
66 The Neuroscientist 21(1)
focal and generalized tonic-clonic seizures since child-
hood. Heuser and colleagues (2010) showed that a com-
bination of three single nucleotide polymorphisms 
(SNPs) in the AQP4 gene (encoding a water channel), 
together with two SNPs in the KCNJ10 gene, was associ-
ated with mTLE. Association analysis in patients with a 
history of febrile seizures (mTLE-FS) revealed that a 
combination of SNPs in KCNJ10, AQP4, and the area 
between KCNJ10 and KCNJ9 was associated with mTLE-
FS (Heuser and others 2012).
Potential Roles of GJs in Epilepsy
Astrocytes in the adult brain are connected to each other 
via GJ channels (Fig. 3) composed of connexin 43 (Cx43) 
and Cx30 (Nagy and Rash 2000), allowing the intercel-
lular exchange of ions, second messengers, metabolites, 
and amino acids. The astroglial syncytium has important 
functions, including spatial buffering of K+ ions 
(see above), delivery of energetic metabolites to neurons 
(Giaume and others 1997), intercellular propagation of 
Ca2+ waves (Scemes and Giaume 2006), volume regula-
tion (Scemes and Spray 1998), and adult neurogenesis 
(Kunze and others 2009).
The role of interastrocytic coupling in the develop-
ment and progression of epilepsy is still controversial 
(Carlen 2012; Nemani and Binder 2005; Steinhäuser and 
others 2012). According to the spatial buffering concept 
(see above), the astroglial network is expected to possess 
antiepileptic function because a reduction of astrocytic 
coupling would result in the accumulation of extracellu-
lar K+, neuronal depolarization, and a lowered threshold 
for seizure generation. In line with this hypothesis are 
results from mice with coupling-deficient astrocytes. In 
these mice, clearance of K+ and glutamate was disturbed. 
They displayed spontaneous epileptiform events, a 
reduced threshold for the generation of epileptic activity, 
and increased synaptic transmission (Pannasch and oth-
ers 2011; Wallraff and others 2006). Although these find-
ings strongly support an anticonvulsive role of glial GJ 
Figure 3. Epilepsy-associated alterations of functional properties in astrocytes. (1) Seizure activity leads to an increase in 
extracellular K+ concentration. Down-regulation of Kir channels was observed in astrocytes in human and experimental 
epilepsy. (2) Gap junctions (GJs) mediate the spatial redistribution of K+. Genetic ablation of GJs entails impaired K+ buffering 
and hyperactivity through neuronal depolarization-induced glutamate release and synchronization. (3) The dislocation of water 
channels contributes to impaired K+ buffering. (4) Astrocytes are primarily responsible for glutamate uptake. Reduction of the 
EAAT1 and EAAT2 proteins is observed in the human epileptic hippocampus. Elevated extracellular glutamate decreases the 
threshold for seizure induction. (5) Glutamate is converted into glutamine through glutamine synthetase (GS). In the human 
epileptic hippocampus, loss of GS resulted in elevated extracellular glutamate levels. In experimental epilepsy, down-regulation 
of GS was observed in the chronic phase. (6) The release of glutamate and ATP from astrocytes through hemichannels may 
promote hyperexcitability. Modified and reproduced with permission from Steinhäuser and Seifert (2012).
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networks, a potential seizure-promoting role emerged 
from the results by Rouach and colleagues (2008), who 
demonstrated that astroglial GJs mediate activity-depen-
dent intercellular trafficking of metabolites from blood 
vessels to sites of high energy demand. The trafficking 
seemed to be essential for the maintenance of synaptic 
activity under pathological conditions such as epilepsy. 
The involvement of GJ channels in the intercellular 
spread of Ca2+ waves also would favor a proconvulsive 
role of the syncytium through neuronal synchronization 
and spread of ictal activity (Gomez-Gonzalo and others 
2010). Thus, astroglial GJ networks might play a dual, 
proepileptic and antiepileptic, role in epilepsy. Future 
work will elucidate which of the mechanisms prevail 
under various circumstances.
Cx Expression and Coupling in Epileptic Tissue
Seizure-induced changes in Cx expression have been 
observed in a variety of animal models and human tissue. 
The results are conflicting and do not allow us to draw 
definitive conclusions. In experimental epilepsy, 
increased (Condorelli and others 2002; Gajda and others 
2003; Mylvaganam and others 2010; Samoilova and oth-
ers 2003; Szente and others 2002; Takahashi and others 
2010), unchanged (Khurgel and Ivy 1996; Li and others 
2001; Söhl and others 2000; Xu and others 2009), and 
decreased (David and others 2009; Elisevich and others 
1997a, 1998; Xu and others 2009) Cx43 and/or Cx30 
transcript and/or protein have been reported. This incon-
sistency might be explained by differences between ani-
mal models, seizure duration, and investigated brain 
areas. In human specimens, mostly up-regulation of the 
Cx43 transcript and/or protein has been described 
(Aronica and others 2001; Collignon and others 2006; 
Fonseca and others 2002; Naus and others 1991), although 
unchanged levels have also been reported (Elisevich and 
others 1997b). However, Cx expression does not neces-
sarily reflect functional coupling because posttransla-
tional modifications may alter unitary conductance, open 
probability, trafficking, or internalization. Hence, func-
tional coupling analyses are indispensable. Increased 
astrocytic coupling has been reported by Takahashi and 
colleagues (2010) in a post-SE model and by Samoilova 
and colleagues (2003) in hippocampal slice cultures 
chronically exposed to bicuculline. In contrast, Xu and 
colleagues (2009) observed reduced coupling in the hip-
pocampal CA1 region in a model of tuberous sclerosis 
complex. Human coupling studies have so far only been 
performed on astrocyte cultures derived from epileptic 
specimens (Lee and others 1995) in which enhanced 
coupling was found with fluorescence recovery after 
photobleaching.
Another approach to assess the role of GJ channels in 
epilepsy is the pharmacological inhibition of interastrocytic 
communication. Such experiments have been performed 
in a variety of in vivo and in vitro models of epilepsy 
(Bostanci and Bagirici 2006, 2007; Gajda and others 
2003; Jahromi and others 2002; Kohling and others 2001; 
Medina-Ceja and others 2008; Perez-Velazquez and oth-
ers 1994; Ross and others 2000; Samoilova and others 
2003, 2008; Szente and others 2002; Voss and others 
2009). Most of these studies reported aniticonvulsive 
effects of GJ blockade, although opposite effects were 
observed by Voss and colleagues (2009). In neocortical 
slices from patients with mTLE or focal cortical dysplasia, 
GJ inhibitors attenuated epileptiform activity (Gigout and 
others 2006). Major problems with GJ blockers are their 
significant side effects and poor Cx isoform specificity.
In conclusion, Cx expression studies and functional 
coupling analyses yield an inconsistent picture of the role 
of the astroglial network in the pathophysiology of epi-
lepsy. Further work is needed to clarify this issue.
Role of Cx Hemichannels in Epilepsy
In addition to intercellular communication, functional 
membrane-spanning Cx hemichannels (HCs) have been 
demonstrated in astrocytes (Fig. 3). These channels are 
nonselective and permeable for large molecules, such as 
ATP, glutamate, glucose, and glutathione. Under normal 
conditions, these channels are closed, but the open prob-
ability increases upon depolarization, altered intracellular 
and extracellular Ca2+ concentration, metabolic inhibi-
tion, or proinflammatory cytokines (Orellana and others 
2013; Theis and Giaume 2012). Activated HCs might 
promote neuronal hyperactivity and hypersynchroniza-
tion through the excessive release of ATP and glutamate, 
which in turn increases excitability and Ca2+ wave propa-
gation (Bedner and Steinhäuser 2013). Furthermore, GJ 
channels and HCs are oppositely regulated by proinflam-
matory cytokines (Meme and others 2006; Retamal and 
others 2007) and may play differential roles in epilepsy. 
In hippocampal slice cultures exposed to bicuculline, 
Yoon and colleagues (2010) showed that selective inhibi-
tion of HCs by low concentrations of mimetic peptides 
had protective effects, while blockade of both HCs and 
GJs by high doses of the peptide exacerbated lesions.
Role of Aquaporin-4 in Regulation of 
Excitability
Aquaporins mediate transmembrane water movements in 
response to osmotic gradients. Among the isoforms iden-
tified so far, aquaporin-4 (AQP4) is the predominant 
water channel in the brain, where it is mainly localized to 
astrocyte perivascular end-feet and perisynaptic pro-
cesses (Papadopoulos and Verkman 2013) (Fig. 3). 
Moreover, AQP4 is implicated in the pathogenesis of 
epilepsy mainly due to its role in regulating extracellular 
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fluid osmolarity and extracellular space (ECS) volume 
(Schwartzkroin and others 1998). Osmolarity-induced 
shrinkage of the ECS causes hyperexcitability (Chebabo 
and others 1995; Dudek and others 1990; Pan and Stringer 
1996; Roper and others 1992), while increasing the ECS 
volume fraction attenuates epileptiform activity (Dudek 
and others 1990; Haglund and Hochman 2005; Pan and 
Stringer 1996; Traynelis and Dingledine 1989). In addi-
tion to ECS regulation, the spatial overlap of AQP4 with 
Kir4.1 in glial end-feet gave rise to the hypothesis that 
AQP4 may be involved in K+ homeostasis (Binder and 
others 2012).
Insight into the role of AQP4 in ECS regulation, K+ 
clearance, and excitability came from transgenic mice: 
AQP4-deficient (AQP4–/–) mice display mild ECS vol-
ume expansion as assessed by Fluorescence Recovery 
After Photobleaching (FRAP) and theTetraMethylAm-
monium+ (TMA+) method (Binder and others 2004b; 
Yao and others 2008). In acute seizure models, AQP4–/– 
mice exhibited an elevated seizure threshold but pro-
longed seizure duration (Binder and others 2004a; Lee 
and others 2012). In addition, in vivo and in situ studies 
using K+-sensitive electrodes or a fluorescent K+ sensor 
revealed impaired stimulus-induced [K+]
o
 clearance in 
AQP4-deficient mice (Binder and Steinhäuser 2006). 
Interestingly, K+ spatial buffering was enhanced in 
AQP4–/– mice probably due to improved GJ coupling 
(Strohschein and others 2011). The expanded ECS vol-
ume found in AQP4-deficient mice offers an explanation 
for the elevated seizure threshold of these mice, while the 
impaired K+ uptake might account for the prolonged 
duration and increased frequency of seizures. However, 
the mechanistic link between AQP4 expression and K+ 
homeostasis has not been resolved yet. The view of a 
functional interaction between AQP4 and Kir4.1 
(Nagelhus and others 1999) is not supported by studies 
showing AQP4-independent Kir4.1 function (Ruiz-
Ederra and others 2007; Strohschein and others 2011; 
Zhang and Verkman 2008). Rather, astrocytic K+ uptake 
during neuronal activity might trigger AQP4-dependent 
water uptake and a reduction of the ECS. In turn, ECS 
shrinkage might increase [K+]
o
 and consequently further 
K+ uptake by astrocytes (Jin and others 2013; 
Papadopoulos and Verkman 2013).
AQP4 Expression and Regulation in Epileptic 
Tissue
Ultimately, AQP4 expression was investigated in hippo-
campi of patients with mTLE using reverse trascrition-
PCR, immunohistochemistry, and gene chip analysis 
(Lee and others 2004). The authors found enhanced 
AQP4 levels in HS but reduced expression of the dystro-
phin gene, which encodes the protein that is involved in 
anchoring AQP4 in perivascular end-feet, and speculated 
that polarity in astrocytic AQP4 distribution got lost. This 
hypothesis was subsequently confirmed with immuno-
gold electron microscopy and Western blot analysis (Eid 
and others 2005). This locally restricted reduction of 
AQP4 was accompanied by a loss of perivascular dystro-
phin, indicating that AQP4 mislocalization was caused 
by a disrupted dystrophin complex. Similar losses of peri-
vascular AQP4 and dystrophin were found in tissue from 
patients with focal cortical dysplasia (Medici and others 
2011). A further indication for the involvement of AQP4 
in epilepsy and for the proposed interplay between AQP4 
and Kir4.1 comes from genetic studies showing that sev-
eral SNPs in the KCNJ10 and AQP4 genes are associated 
with mTLE (Heuser and others 2010) (see also below).
In a recent study, Alvestad and colleagues (2013) 
explored in a kainate model whether the loss of perivascu-
lar AQP4 found in human mTLE is involved in epilepto-
genesis or merely represents a consequence of the 
condition. They demonstrated that AQP4 mislocalization 
precedes the chronic phase of epilepsy, suggesting that 
astrocytic dysfunction is of pathophysiological relevance.
Glutamate: Transporters and 
Degradation
Extracellular Glutamate Levels in TLE
The rapid clearance of excessive glutamate from the ECS 
and the recycling of glutamate are important processes 
for brain function. To prevent excitotoxic accumulation 
in the ECS, glutamate is taken up by astrocytes via trans-
porters, converted to glutamine by the enzyme glutamine 
synthetase (GS), and shuttled back to neurons for resyn-
thesis of glutamate (Fig. 3). Dysfunction of glutamate 
metabolism seems to be critically involved in the patho-
physiology of epilepsy (Coulter and Eid 2012). 
Accordingly, glutamate and its analogs cause seizures 
and neuronal loss in experimental epilepsy (Ben-Ari 
1985; Fremeau and others 2002; Nadler and Cuthbertson 
1980; Olney and others 1972). Increased extracellular 
glutamate levels were found in the hippocampi of patients 
with mTLE (Cavus and others 2005; During and Spencer 
1993). Patients with HS displayed the highest interictal 
glutamate levels (Petroff and others 2003). However, the 
source of glutamate in HS is obscure because one of the 
hallmarks of this pathology is the loss of glutamatergic 
neurons in the hippocampal CA1 region.
Astrocytic Glutamate Uptake in Epilepsy
Uptake of glutamate from the ECS is driven by the elec-
trochemical gradients. Five transporter isoforms have 
been identified, and two of them, GLAST (EAAT1) and 
GLT1 (EAAT2), are preferentially expressed in astro-
cytes (Fig. 3). The impact of astrocytic glutamate uptake 
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became obvious from mice devoid of transporter pro-
teins. GLT1 knockout mice displayed enhanced seizure 
susceptibility (Tanaka and others 1997). The pharmaco-
logical inhibition of GLT1 in the rat neocortex reduced 
the threshold for evoking epileptiform activity (Campbell 
and Hablitz 2004; Demarque and others 2004). In con-
trast, knockdown of GLT1 caused increased extracellular 
glutamate, but not seizures (Rothstein and others 1996). 
Mice deficient in GLAST showed no spontaneous sei-
zures, but amygdala kindling or provoked seizures were 
of longer duration, were more severe, and occurred after 
a shorter latency (Watanabe and others 1999).
In patients with mTLE, data on the regulation of GLT1 
and GLAST are inconsistent. Decreased GLT1 and 
GLAST levels were found by Mathern and colleagues 
(1999) and Proper and colleagues (2002), while Tessler 
and colleagues (1999) and Eid and colleagues (2004) 
reported no changes. In kindled rats, unchanged GLT1 
and GLAST levels were described (Akbar and others 
1997; Miller and others 1997; Simantov and others 1999), 
while decreased levels were found in pilocarpine (Lopes 
and others 2013) and albumin models (David and others 
2009) as well as in tuberous sclerosis (Wong and others 
2003). Finally, Guo and colleagues (2010) observed 
decreased GLAST but unaffected GLT1 expression in the 
hippocampus of spontaneously epileptic rats.
Together, these studies indicate that astrocytic gluta-
mate uptake plays a crucial role in protecting neurons 
from hyperexcitability. However, how exactly this mech-
anism is disturbed in epilepsy is still under discussion.
Regulation of GS in Epilepsy
In the CNS, GS is predominantly expressed by astrocytes, 
where it converts glutamate and ammonia to glutamine 
(Fig. 3). Impaired GS activity plays a crucial role in the 
pathogenesis of mTLE (Eid and others 2013b). Thus, 
intrahippocampal infusion of a GS inhibitor caused recur-
rent seizures and neuropathological changes similar to 
human mTLE (Eid and others 2008; Perez and others 
2012; Wang and others 2009). Moreover, decreased GS 
protein and enzyme activities, probably due to posttran-
scriptional modification (Eid and others 2013a), have 
been found in patients with mTLE-HS (Eid and others 
2004; van der Hel and others 2005) (Fig. 4). Finally, 
mutations in the GS encoding gene, GLUL, are associated 
with reduced GS activity and seizures (Haberle and oth-
ers 2005, 2006, 2011). One argument against a causative 
role for GS dysfunction in epileptogenesis, however, 
arises from the study by Hammer and colleagues (2008), 
who in a kainate model confirmed decreased GS proteins 
in the chronic phase but reported increased GS levels in 
the latent period (prior to seizure onset). The link between 
GS down-regulation and seizure development is based on 
the assumption that GS deficiency causes intracellular 
glutamate accumulation. This accumulation, in turn, 
slows down glutamate uptake, leading to increased gluta-
mate levels in the ECS. Indeed, GS inhibition entails glu-
tamate accumulation in hippocampal astrocytes (Perez 
and others 2012).
Interruption of the glutamate-glutamine cycle through 
GS inhibition impairs inhibitory GABAergic transmis-
sion (Liang and others 2006) but has little effect on excit-
atory synaptic function (Kam and Nicoll 2007). The 
consequences of this relationship have been studied in a 
model of astrocytic gliosis with GS down-regulation, 
which produced a deficit in inhibitory, but not excitatory, 
synaptic transmission. Employing voltage-sensitive dye 
imaging, the authors showed that these inhibitory deficits 
entail network hyperexcitability, which could partially be 
reversed by exogenously supplied glutamine. These data 
emphasize the importance of proper GS function for 
inhibitory neurotransmission and the prevention of hyper-
excitability (Ortinski and others 2010).
Astrocyte Ca2+ Signaling, 
Gliotransmitter Release, and 
Epileptiform Discharges in TLE
As a consequence of Ca2+ elevations, astrocytes can 
release gliotransmitters that differently modulate neuro-
nal excitability and synaptic transmission. Some of these 
gliotransmitters, such as glutamate, D-serine, and ATP, 
have been proposed to be released through a Ca2+-
dependent mechanism that involves vesicle exocytosis 
(Bezzi and others 2004; Martineau and others 2013; 
Parpura and Zorec 2010), lysosome exocytosis (Li and 
others 2008; Zhang and others 2007), or permeation 
through ion channel openings upon intracellular Ca2+ 
elevations (Takano and others 2005; Woo and others 
2012) (Fig. 1). Gliotransmitter Ca2+-independent release 
mechanisms have been also identified and rely on the 
opening of large pore channels, such as anion channels 
and P2X7 receptors, or the reversal operation of gluta-
mate transporters (Fellin and Carmignoto 2004; Parpura 
and others 2004). While we cannot exclude that Ca2+-
dependent and Ca2+-independent gliotransmitter release 
mechanisms coexist and are operative under different 
conditions, from the presence of astrocyte Ca2+ eleva-
tions, we can infer that gliotransmitter release is operative 
in these cells. Below, we discuss recent studies that 
described an enhancement of Ca2+ signals in astrocytes 
and a synchronization of neuronal activities by gliotrans-
mitter release during epileptiform activity.
Astrocyte Ca2+ Signals
If astrocytes contribute to the generation of seizures, it is 
expected that not only neurons but also astrocytes are 
hyperactive in epileptic brain circuits. Recent studies 
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Figure 4. Decreased glutamine synthetase (GS) immunoreactivity in the CA1 region of patients with medial temporal lobe 
epilepsy (mTLE). There is a dense and even distribution of GS-positive cells in the subiculum and CA1 region of autopsy (A) and 
non-mTLE hippocampi (D). High-power fields of the subiculum in autopsy (B) and non-mTLE (E) hippocampi show that staining 
is confined to astrocytes. High-power fields of the CA1 area in autopsy (C) and non-mTLE (F) hippocampi also show many 
GS-positive astrocytes. In the mTLE hippocampus (G), there are many GS-positive cells in the subiculum, but the CA1 area is 
severely deficient in GS staining. High-power view of the subiculum in G (H) confirms the presence of staining in astrocytes, 
which have fewer processes than GS-positive astrocytes in the corresponding areas of autopsy (B) and non-mTLE hippocampi (E). 
(I) High-power view of the CA1 area in G confirms the lack of GS staining in this region. Specificity controls with GS antiserum 
(J) and preimmune serum (K) on adjacent sections of the non-mTLE hippocampus shown in D to F reveal no staining in K. DG = 
dentate gyrus. Modified and reproduced with permission from Eid and others (2004).
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provided evidence that during epileptiform activities, 
Ca2+ signaling in astrocytes is indeed enhanced. For 
example, in rat hippocampal slices in which network 
excitability was enhanced by reducing external Mg2+ and 
by blocking inhibitory synapses with the GABA
A
 recep-
tor antagonist picrotoxin, both the number of astrocytes 
displaying Ca2+ oscillations and the frequency of Ca2+ 
peaks were significantly increased (Fellin and others 
2006). The increased Ca2+ oscillation frequency corre-
lated with an increased frequency of the slow inward cur-
rents (SICs) observed under these conditions in pyramidal 
neurons. In vivo studies also showed that epileptiform 
activities induced by various pharmacological treatments 
were associated with an increased frequency of Ca2+ 
oscillations in cortical astrocytes (Ding and others 2007; 
Tian and others 2005). Interestingly, in the same in vivo 
models of epilepsy, the increase in Ca2+ oscillation fre-
quency was reduced by the systemic administration of 
anticonvulsant drugs, such as valproate, gabapentin, and 
phenytoin (Tian and others 2005). Consistent with an 
increased activity of astrocytes in the epileptic brain, the 
astrocytic expression of the metabotropic glutamate 
receptors (mGluRs), which mediates the Ca2+ response of 
astrocytes to synaptically released glutamate, is increased 
in animal models of TLE (Aronica and others 2000; Ulas 
and others 2000).
Altogether, these data indicate that a significant cor-
relation exists between an increase in astrocyte Ca2+ 
oscillations and the emergence of epileptiform activities 
and suggest that astrocytes may contribute to the genera-
tion of epileptic discharges.
Gliotransmitter Release
An experimental observation that provided further sup-
port to the potential role of astrocytes and Ca2+-dependent 
gliotransmission in the generation of epileptiform activi-
ties was obtained in young rat hippocampal slices (Fellin 
and Carmignoto 2004). In these experiments, Ca2+ eleva-
tions evoked in astrocytes by various stimuli that acti-
vated G protein–linked receptors, including the synaptic 
release of glutamate induced by Schaffer collateral stimu-
lation, were followed by the generation in pyramidal CA1 
neurons by SICs (Fellin and others 2004). These events 
appear to originate from a Ca2+-dependent release of glu-
tamate from astrocytes as they were insensitive to the 
block of action potential–dependent glutamate release 
from neurons by tetrodotoxin (TTX); could be induced 
by photolysis of a Ca2+-caged compound loaded into indi-
vidual astrocytes; and were mediated by extrasynaptic, 
high-affinity N-methyl D-aspartate receptor 2B (NR2B)–
containing N-methyl-D-aspartate receptors (NMDARs) 
(Fellin and Carmignoto 2004). Similar events have 
been subsequently observed in different brain regions, 
including the thalamus (Parri and others 2001), nucleus 
accumbens (D’Ascenzo and others 2007; Fellin and oth-
ers 2007), olfactory bulb (Kozlov and others 2006), brain 
stem (Reyes-Haro and others 2010), spinal cord (Bardoni 
and others 2010), and neocortex (Ding and others 2007). 
In relation to a potential role of astrocytic glutamate in 
epileptiform activity, it is worth stressing here that SICs 
can occur with a high level of synchrony among two 
nearby pyramidal neurons (Angulo and others 2004; 
Fellin and Carmignoto 2004). Given that excessive neu-
ronal synchronization in local networks is one of the hall-
marks of epileptic disorders, SICs may be involved in the 
generation of epileptiform activity. In addition, the obser-
vation that SICs can depolarize the neuronal membrane 
to the action potential discharge threshold (Fellin and 
others 2006; Pirttimaki and others 2011) suggests that 
astrocytic glutamate, initially acting on one or two neu-
rons, may enlarge its action to synaptically connected 
neurons and promote focal epileptiform discharges by 
recruiting large neuronal populations into synchronous 
bursts. Consistent with this hypothesis, confocal micro-
scope Ca2+ imaging experiments, which allow us to eval-
uate neuronal network activities by monitoring 
simultaneously the Ca2+ signal dynamics from tens of 
neurons, revealed that astrocytic glutamate triggers 
simultaneous NMDA receptor–mediated Ca2+ increases 
in groups of CA1 neurons, an event that was termed a 
“domain response” (Fellin and others 2004). It is impor-
tant to underline that the proconvulsant action of astro-
cytic glutamate may have more impact in regions that are 
rich with recurrent axon collaterals, such as the hippo-
campus and other limbic structures, where it may repre-
sent a nonneuronal mechanism that favors neuronal 
synchrony (Carmignoto and Fellin 2006).
The hypothesis that the activation-induced glutamate 
release from astrocytes is directly involved in the gener-
ation of epileptic events was specifically investigated in 
a number of in vitro and in vivo studies. A study by Tian 
and colleagues (2005), using different slice models of 
chemically induced epilepsy, proposed the paroxysmal 
depolarizing shifts (PDSs) that characterize interictal 
epileptiform events to correspond in large part to the 
depolarizing events generated by SICs and thus result 
from the release of glutamate from astrocytes, which 
were strongly activated under these experimental condi-
tions. In favor of an astrocytic origin of PDSs, the authors 
showed that a large majority of these events were insen-
sitive to action potential inhibition by the Na+ channel 
blocker TTX. These observations were, however, at vari-
ance with results obtained in a number of studies report-
ing a sensitivity to TTX of interictal discharges (Fellin 
and others 2006; Gomez-Gonzalo and others 2010; 
Perreault and Avoli 1991; Stasheff and others 1993). 
Also, differences in the sensitivity of PDSs and SICs to 
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NMDA receptor blockers—that is, D-AP5 abolished 
SICs, but not PDSs—render unlikely that PDSs coincide 
with astrocyte-mediated SICs. It thus appears that PDSs 
and SICs share similar kinetics but are distinct events 
generated by two different cellular sources (D’Ambrosio 
2006; Wetherington and others 2008). Subsequent stud-
ies clarified that astrocyte Ca2+ signals leading to gluta-
mate release cooperate with neurons in the generation of 
an epileptogenic focus rather than represent a direct 
cause of the epileptic discharge. In a young rat cortical 
slice model of TLE, Gomez-Gonzalo and colleagues 
(2010) showed that local NMDA applications to entorhi-
nal cortex layer V to VI neurons, in the presence of the 
proconvulsant 4-aminopyridine and low external Mg2+, 
can trigger focal seizure–like discharges. The authors 
observed that two subsequent, but not single, NMDA 
pulse stimulations evoked both a synchronous and 
intense firing discharge in a small group of neurons and 
early Ca2+ elevations in astrocytes. This local response 
was regularly followed by a seizure-like event that 
emerged at the focus with a few seconds’ delay and later 
propagated to distant brain regions. The early Ca2+ ele-
vation in astrocytes represented a central event in 
NMDA-induced seizure generation. Indeed, after a dras-
tic reduction of the Ca2+ increase by the Ca2+ chelator 
1,2-bis(o-amino-phenoxy)ethane-N,N,N’,N’-tetraacetic 
acid (BAPTA), by patching individual astrocytes with a 
BAPTA-containing pipette that allows the spreading of 
BAPTA throughout the astrocyte syncytium, double 
NMDA stimulation, which normally triggered a seizure 
discharge, became unsuccessful. Importantly, weak 
NMDA stimulation, composed of a single NMDA pulse 
that failed to trigger both Ca2+ signals in astrocytes and 
seizures, became successful when it was coupled with a 
stimulus that triggered Ca2+ elevations in astrocytes, 
such as L- Threonyl- L- phenylalanyl- L- leucyl- L- leucyl- L- 
argininamide (TFLLR), that is, a peptide that activates 
thrombin protease-activated receptor 1. Of note, this 
receptor is highly, if not selectively, expressed in astro-
cytes of the entorhinal cortex, and it is known to mediate 
glutamate release in these cells (Fellin and others 2004). 
As a whole, these data suggest that astrocytic Ca2+ sig-
nals induced in astrocytes by neurons through NMDA 
applications evoke the release of gliotransmitters, such 
as glutamate and possibly D-serine, which enhanced 
NMDA receptor activation. This, in turn, leads to the 
recruitment of a critical mass of neurons that, in turn, 
generates a focal seizure discharge (Gomez-Gonzalo 
and others 2010).
The initiation of a seizure discharge at the epilepto-
genic focus may thus be due to the intense firing of a criti-
cal mass of neurons in a recruitment process that involves 
an excitatory loop between neurons and astrocytes. 
When astrocytes are consistently engaged by an episode 
of hyperactivity in a group of neurons, they signal back 
by a Ca2+-dependent gliotransmitter activity that increases 
the basic excitability of brain microcircuits. If this feed-
back signal operates on a brain network that is abnor-
mally hyperactive as a consequence of trauma, high 
temperature, or genetic defects, it will contribute to drive 
neurons towards the seizure discharge threshold.
A recent study in Drosophila provides further support 
to this conclusion. The study by Melom and Littleton 
(2013) reported that in the Drosophila brain, a mutation 
of the glial-specific K+-dependent Na+/Ca2+ exchanger in 
brain glia leads to a series of defective features in these 
cells, including an increase in Ca2+ basal levels and a sup-
pression of microdomain Ca2+ oscillations that are nor-
mally observed in controls. Most importantly, these zyd 
mutants exhibit an enhancement of seizure susceptibility 
to increased temperature. Given that these glial cells form 
in the Drosophila brain a honeycomb network, in a fash-
ion similar to the mosaic distribution of astrocytes in the 
mammalian brain, and also that they encapsulate indi-
vidual neuronal somata similarly to the typical anatomic 
features of astrocytic processes, these glial cells are in a 
privileged position to exchange with neurons’ functional 
signals. The authors indeed suggested that in zyd mutants, 
glia exhibiting high Ca2+ basal levels respond to a stress-
ful environmental stimulus with an additional Ca2+ 
increase that, through glia-to-neuron signaling, initiates a 
seizure-inducing process. Consistent with the role of glia 
Ca2+ elevations in seizure generation, they induced a 
selective expression of the heat-activated TRPA1 chan-
nels in glia and observed a strong, immobilizing seizure 
within seconds of TRPA1 stimulation by a temperature 
shift to 30°C. Although it remains to be fully investigated 
how glia signal to neurons in this model, this study pro-
vides further support for a direct role of glia in seizure 
generation.
In addition to enhancing the excitability of single neu-
rons and favoring neuronal synchronies, the release of 
glutamate from astrocytes contributes to the delayed neu-
ronal death that characterizes chronic epileptic conditions 
(Ding and others 2007). During SE, astrocytes are highly 
activated, and the consequent glutamate release can trig-
ger neuronal damage through an excessive activation of 
NR2B-containing NMDA receptors. The inhibition of 
astrocyte Ca2+ signals by the mGluR antagonist 2-Methyl-
6-(phenylethynyl)pyridine (MPEP) as well as the block 
by ifenprodil of extrasynaptic 2B subunit–containing 
NMDA receptors, that is, the neuronal targets of astro-
cytic glutamate, reduce the delayed neuronal death that 
characterizes this pathological condition (Ding and oth-
ers 2007). Consistent with the role of extrasynaptic 
NR2B-containing NMDA receptors in cell death during 
SE is the finding that activation of this receptor subtype 
results in mitochondrial dysfunction and stimulates both 
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dephosphorylation of the cyclic adenosine monophos-
phate response element binding protein and neuronal 
death following hypoxic ischemic insults or head injuries 
(Hardingham and others 2002).
Role of Astrocytes in Absence 
Seizures
Astrocytic GABA Transporters
Classically, epilepsy is viewed as originating either 
from enhanced glutamatergic transmission, decreased 
GABAergic transmission, or both. Thus, the mutations 
in GABA
A
 receptor genes of patients with absence sei-
zures (Kananura and others 2002; Lachance-Touchette 
and others 2011; Maljevic and others 2006; Macdonald 
and others 2010; Wallace and others 2001) have always 
been interpreted as leading to a widespread loss of func-
tion in GABA
A
R-mediated synaptic transmission. 
However, in transgenic mice carrying one of this human 
GABA
A
R point mutations (i.e., R43Q in the γ subunit) 
(Wallace and others 2001), abnormalities in GABAergic 
transmission (i.e., decreased inhibitory postsynaptic 
current [IPSC] frequency) are present in cortical but not 
in thalamic reticular or thalamocortical neurons (Tan 
and others 2007). Indeed, many pieces of independent 
evidence indicate that in thalamocortical neurons of 
sensory thalamic nuclei of many absence epilepsy mod-
els, the GABAergic function is not decreased but is 
either increased or unchanged. In particular, 1) in 
Genetic Absence Epilepsy Rats from Strasbourg 
(GAERS), a well-established genetic absence model 
(Danober and others 1998), thalamocortical neurons 
show rhythmic bursts of GABA
A
 inhibitory postsynap-
tic potentials (IPSPs) during absence seizures (Pinault 
and others 1998); 2) the thalamic injection of penicillin 
(Kostopoulos 2000) or bicuculline (Steriade and 
Contreras 1995) fails to elicit absence seizures; 3) in 
many mouse models, there is no change or an increased 
phasic GABA
A
R-mediated inhibition (i.e., IPSPs or 
IPSCs) in thalamocortical neurons compared to their 
respective nonepileptic control strains (Bessaih and oth-
ers 2006; Caddick and others 1999; Cope and others 
2009; Tan and others 2008); 4) GABA levels in the 
thalamus of GAERS are higher than in the nonepileptic 
control strain (Richards and others 1995); and 5) 
GABA
B
R agonists induce absence seizures in naïve ani-
mals and aggravate them in different models of this non-
convulsive epilepsy (Aizawa and others 1997; Danober 
and others 1998; Snead 1992). Importantly, drugs that 
increase GABA levels, that is, vigabatrin and tiagabine, 
induce absence seizures in animals and humans as well 
as aggravate them in animal models of, and in patients 
suffering from, absence epilepsy (Danober and others 
1998; Ettinger and others 1999; Hosford and Wang 
1997; Panayiotopoulos 2001; Perucca and others 1998).
In line with these findings, tonic GABA
A
 inhibition in 
thalamocortical neurons is increased in mouse and rat 
genetic and pharmacological models of absence epilepsy, 
including GAERS, stargazer, and lethargic and succinic 
semialdehyde dehydrogenase knockout animals as well as 
in the γ-hydroxybutyric acid (GHB) and 4,5,6,7-tetrahy-
droisoxazolo-[5,4-C]pyridine-3-ol (THIP) models (Cope 
and others 2009; Errington and others 2011b). Moreover, 
absence seizures in GAERS are blocked by the thalamic 
injection of a GABA
A
R δ subunit–specific antisense oligo-
deoxynucleotide and cannot be induced in GABA
A
R 
δ-subunit knockout mice (Cope and others 2009). Together, 
these data suggest a potential therapeutic role for inverse 
agonists at perisynaptic/extrasynaptic δ-GABA
A
Rs in 
absence epilepsy (Errington and others 2011a).
The increased tonic GABA-A current in thalamocorti-
cal neurons of genetic mouse and rat models does not 
result from an enhanced activity of perisynaptic/extra-
synaptic δ subunit–containing GABA
A
Rs, but it is due to 
a loss of function of one of the GABA transporters, 
GAT-1 (Cope and others 2009) (Fig. 5), which in the 
thalamus of both humans and rodents is exclusively 
located in astrocytes (Borden 1996; De Biasi and others 
1998; Pow and others 2005). This conclusion is based 
both on indirect evidence (i.e., measurements of the tonic 
Figure 5. Astrocytic molecular players in absence epilepsy. 
GABAergic synapses in the sensory thalamus show a 
decreased function of the astrocytic GABA transporter 
GAT-1, while in the somatosensory cortex, interleukin-1β 
levels are increased. Astrocytic thalamic gap junctions, that 
is, connexin 30 and connexin 43, also contribute to absence 
seizure generation. Modified and reproduced with permission 
from Crunelli and Carmignoto (2013).
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GABA
A
 current in GAERS and stargazer mice) (Cope 
and others 2009) and direct evidence showing that the 
GABA transporter current measured from patch-clamped 
astrocytes in GAERS thalamic slices is not affected by 
NO-711 (a selective blocker of GAT-1) but is abolished 
by SNAP5114, a selective blocker of GAT-3 (Pirttimaki 
and others 2012).
Interestingly, the thalamic expression of GAT-1 in 
GAERS and stargazer mice is similar to that of their 
respective nonepileptic control strains, and only a silent 
mutation is present in the GAT-1 gene of these two 
genetic models (Cope and others 2009). So, it may be 
possible that the inability of GAT-1 to regulate GABA 
levels is because this transporter remains as an immature 
intracellular protein or, alternatively, that the phosphory-
lation of GAT-1, and thus its function, is compromised. 
Moreover, one might expect GAT-3, the only other 
GABA transporter in the thalamus (Borden 1996; De 
Biasi and others 1998; Pow and others 2005), to compen-
sate for the malfunctioning GAT-1, but this is not the 
case. It might also be that GAT-3 is located far away from 
the perisynaptic/extrasynaptic GABA
A
Rs that are respon-
sible for the tonic GABA
A
 current, although a recent 
investigation concluded that GAT-1 is “primarily local-
ized near GABAergic synapses whereas GAT-3 is local-
ized both near and far away from synapses” (Beenhakker 
and Huguenard 2010). Clearly, more direct studies inves-
tigating the relative position of these transporters with 
respect to synaptic and perisynaptic/extrasynaptic 
GABA
A
Rs are necessary to resolve this issue.
Astrocyte-Neuron Signaling in Absence 
Seizures
Slow outward currents (SOCs) are the characteristic sig-
natures of GABAergic astrocyte-to-neuron signaling 
(Kozlov and others 2006). Possibly as a consequence of 
reduced GAT-1 activity in the thalamus, some properties 
(i.e., amplitude, rise time, and decay time) of SOCs are 
altered in GAERS thalamocortical neurons (Pirttimaki 
and others 2011, 2012). At present, one cannot ascribe a 
precise mechanistic significance for these changes in tha-
lamic SOCs to the pathophysiological processes underly-
ing absence seizures. Nevertheless, it is interesting that 
vigabatrin, which elicits and/or exacerbates absence sei-
zures in animals and humans (see above), can increase 
the frequency of SOCs in thalamic neurons (Jimenez-
Gonzalez and others 2011).
Importantly, no differences are observed in the proper-
ties of SICs, the characteristic signature of glutamatergic 
astrocyte-to-neuron signaling (Angulo and others 2004; 
Fellin and others 2004), between GAERS prior to seizure 
onset and age-matched nonepileptic rats (Pirttimaki and 
others 2012). Moreover, no change in astrocytic gluta-
mate transporters has been reported at this age in the 
thalamus of this genetic model (Dutuit and others 2002).
It is now well established that, contrary to the classic 
view, absence seizures are not generalized from their 
very start, but there is an “initiation site” in a localized 
cortical region both in experimental models (Meeren and 
others 2002; Polack and others 2007) and in humans (Bai 
and others 2010; Holmes and others 2004; Moeller and 
others 2010; Westmijse and others 2009). Thus, it is 
important that future studies investigate whether similar 
abnormalities to those present in the activity of GAT-1 
and SOCs are also present in the cortical “initiation site” 
of rat genetic models and humans suffering from this 
form of epilepsy. Indeed, in cortical neurons, one might 
expect to see alterations in SICs because glutamate uptake 
is reduced in this brain region of preseizure GAERS 
(Touret and others 2007) as a result of a decreased expres-
sion of the astrocytic glutamate transporters GLT1 and 
GLAST (Dutuit and others 2002).
Other Astrocytic Abnormalities in Absence 
Seizures
Another recent finding that stresses the potential role of 
astrocytic abnormalities in the expression of absence sei-
zures is the selective induction of IL-1β in activated 
astrocytes within the cortical “initiation site” of absence 
seizures (i.e., the peri-oral region of the somatosensory 
cortex) (Fig. 5), but not in other cortical regions or in the 
thalamus of GAERS prior to seizure onset (Akin and oth-
ers 2011). This enhanced cortical expression of IL-1β is 
not simply an epiphenomenon because the systemic 
injection of a specific blocker of IL-1β synthesis drasti-
cally decreases absence seizures in this model (Akin and 
others 2011) and the injection of an IL-1β inducer 
increases the number of absence seizures in WAG/Rij 
rats (Kovács and others 2006), another well-established 
model of absence epilepsy (Coenen and Van Luijtelaar 
2003). Unfortunately, no data are available on the levels 
of IL-1β in humans before or after the onset of absence 
seizures.
Finally, it is important to note that the ability of the GJ 
blocker carbenoxolone to drastically reduce absence sei-
zures in both rat (WAG/Rij) and mouse (lethargic) mod-
els when it is injected intrathalamically or systemically 
(Gareri and others 2005) (Fig. 5), respectively, has been 
mainly explained as resulting from a block of neuronal 
GJs. While strong evidence exists for neuronal GJs in the 
thalamus (Hughes and others 2004, 2011; Landisman and 
others 2002; Nagy and Rash 2000; Söhl and others 2005), 
both the reticular thalamic nucleus and the sensory tha-
lamic nuclei also exhibit strong immunoreactivity for the 
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astroglia-specific Cx30 and Cx43 (Nagy and Rash 2000) 
(Fig. 3). Thus, astrocytic GJs are also likely to play a role 
in the antiabsence effect of carbenoxolone and in the 
mechanisms underlying the expression of absence sei-
zures (Fig. 5).
Conclusions
The findings reviewed here highlight novel key elements 
of astrocytic involvement in epilepsy, in particular, 
abnormalities in the astrocyte control of extracellular K+, 
Ca2+ signaling, and gliotransmitter release in mTLE and 
abnormalities in GAT-1, Cx30- and Cx43-based GJs, and 
the IL-1β pathway in absence seizures. This shift in 
research from neurons to astrocyte-neuron interactions 
(Crunelli and Carmignoto 2013; Steinhäuser and others 
2012) has allowed us to unravel novel mechanisms under-
lying the generation of seizures (Baulac and Pitkanen 
2009). These novel astrocyte-based targets should pave 
the way to a rational discovery program for the develop-
ment of fourth-generation antiepileptogenic drugs with 
increased efficacy that many expert groups have identi-
fied as a key priority for the improved clinical manage-
ment of convulsive and nonconvulsive epilepsy (Baulac 
and Pitkanen 2009; Galanopoulou and others 2012; 
Löscher and Schmidt 2011; Simonato and others 2012).
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